Article
Prostate Cancer Gene Therapy Clinical Trials
3 Apr 2007
Abstract excerpt
Despite recent advances in early detection and treatment, prostate cancer is still the second leading cause of cancer death in men in the United States, and approximately 27,000 men will die from it this year. Better treatments are needed for aggressive forms of localized disease and hormone-refractory metastatic disease. Recently, several gene therapy strategies have generated provocative results in early-stage...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
